Caris Life Sciences Right-In-Time Clinical Trial Solution Expands Access to Precision Oncology Trials for Historically Underserved Cancer Patients
Go back to Caris Life Sciences Right-In-Time Clinical Trial Solution Expands Access to Precision Oncology Trials for Historically Underserved Cancer Patients| CACI INTERNATIONAL CLA (NASDAQ: CAI) | Delayed: 17.31 -1.16 (6.28%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $18.47 | 52 Week High | $11.53 | |||
| Open | $18.61 | 52 Week Low | $4.83 | |||
| Day High | $18.79 | P/E | 5.87 | |||
| Day Low | $17.27 | EPS | $2.95 | |||
| Volume | 3,023,468 | |||||
